Published in Presse Med on April 07, 2001
Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet (1999) 5.14
Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships. J Clin Microbiol (1993) 4.36
Fatal enterovirus 71 encephalomyelitis. J Pediatr (1998) 3.39
Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8. J Clin Microbiol (1987) 3.17
Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide. Infect Immun (1984) 3.14
Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus. J Clin Microbiol (1985) 2.97
Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics. J Antimicrob Chemother (1999) 2.80
Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur J Clin Microbiol Infect Dis (1988) 2.71
Hypothalamic-pituitary-gonadal dysfunction in men using cimetidine. N Engl J Med (1979) 2.61
Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens. Eur J Clin Microbiol Infect Dis (1993) 2.42
Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor. Infect Immun (1989) 2.30
Nucleotide sequences of the genes coding for the TEM-like beta-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol Lett (1994) 2.24
Diffusion weighted MR imaging of 5-fluorouracil and oxaliplatin-induced leukoencephalopathy. J Postgrad Med (2013) 2.05
Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors. J Antimicrob Chemother (1992) 2.04
Prevalence of capsular polysaccharide types 5 and 8 among Staphylococcus aureus isolates from cow, goat, and ewe milk. J Clin Microbiol (1988) 1.87
Halobacterial flagellins are sulfated glycoproteins. J Biol Chem (1985) 1.85
A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital--the SCOAST study. Int J Clin Pract (2008) 1.74
Peer support for patients with type 2 diabetes: cluster randomised controlled trial. BMJ (2011) 1.69
Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase. Infect Immun (2000) 1.68
Direct testing of blood culture for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureus. J Clin Microbiol (1989) 1.61
Frozen biopsy specimens and culture rates of Helicobacter pylori. Lancet (1991) 1.57
Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit. J Hosp Infect (2005) 1.56
Nosocomial infections by chlorhexidine solution contaminated with Pseudomonas pickettii (Biovar VA-I). J Infect (1983) 1.55
One-step immunochromatographic dipstick tests for rapid detection of Vibrio cholerae O1 and O139 in stool samples. Clin Diagn Lab Immunol (2003) 1.54
Correlation between esterase electrophoretic types and capsular polysaccharide types 5 and 8 among methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus. J Clin Microbiol (1990) 1.54
Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Crit Care Med (1996) 1.52
Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to beta-lactamase inhibitors. FEMS Microbiol Lett (1994) 1.50
Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis. J Clin Microbiol (1988) 1.50
Arthroplastic and osteosynthetic infections due to Propionibacterium acnes: a retrospective study of 52 cases, 1995-2002. Eur J Clin Microbiol Infect Dis (2005) 1.45
Structure of the type 5 capsular polysaccharide of Staphylococcus aureus. Carbohydr Res (1990) 1.44
Occurrence of pathogenic vibrios in coastal areas of France. J Appl Microbiol (2002) 1.43
The novel epidemic strain O139 is closely related to the pandemic strain O1 of Vibrio cholerae. J Infect Dis (1994) 1.43
Sepsis-associated purpura fulminans in adults. Wien Klin Wochenschr (2001) 1.43
Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines. Vet Rec (2006) 1.42
Use of dipsticks for rapid diagnosis of cholera caused by Vibrio cholerae O1 and O139 from rectal swabs. J Clin Microbiol (2003) 1.42
[Plasmid resistance to 3d generation cephalosporins]. Presse Med (1988) 1.41
Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases. Antimicrob Agents Chemother (1997) 1.39
Regulation of Staphylococcus aureus capsular polysaccharide type 5: CO2 inhibition in vitro and in vivo. J Infect Dis (1997) 1.38
Staphylococcus aureus growth and type 5 capsular polysaccharide production in synthetic media. Appl Environ Microbiol (1991) 1.36
Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations. Infect Immun (1981) 1.33
Involvement of the accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by Staphylococcus aureus. J Gen Microbiol (1993) 1.33
Epidemiological markers for epidemic strain and carrier isolates in an outbreak of nosocomial oxacillin-resistant Staphylococcus aureus. J Clin Microbiol (1990) 1.29
Pathogenesis of diarrhoea caused by astrovirus infections in lambs. Arch Virol (1979) 1.28
Production of type 5 capsular polysaccharide by Staphylococcus aureus grown in a semi-synthetic medium. J Gen Microbiol (1991) 1.28
On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba. J Biol Chem (1998) 1.25
Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis (1992) 1.23
Genetic analysis of the cap5 locus of Staphylococcus aureus. FEMS Microbiol Lett (1999) 1.22
Optical matter: crystallization and binding in intense optical fields. Science (1990) 1.22
Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol (2001) 1.21
Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity. Proc Natl Acad Sci U S A (2000) 1.21
Individualisation of two new genomic groups among American Borrelia burgdorferi sensu lato strains. FEMS Microbiol Lett (1994) 1.20
Two variants of transferrable extended-spectrum TEM-beta-lactamase successively isolated from a clinical Escherichia coli isolate. FEMS Microbiol Lett (1992) 1.18
Cholera in Madagascar. Lancet (1999) 1.16
Regulation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides by CO(2). J Bacteriol (2001) 1.12
Asparaginyl-N-acetylgalactosamine. Linkage unit of halobacterial glycosaminoglycan. J Biol Chem (1986) 1.11
Injury Severity Score (ISS) as a yardstick in assessing the severity and mortality of various abdomino-pelvic trauma hospitalized victims--a clinical vis-à-vis autopsy study. Med Sci Law (1989) 1.10
Nucleotide sequence of the bla(RTG-2) (CARB-5) gene and phylogeny of a new group of carbenicillinases. Antimicrob Agents Chemother (2000) 1.08
Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients. Intensive Care Med (2001) 1.08
Emergence of cholera in the Central African Republic. Eur J Clin Microbiol Infect Dis (1998) 1.07
Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone. Exp Clin Endocrinol Diabetes (2007) 1.07
Diagnosing Staphylococcus aureus endocarditis by detecting antibodies against S. aureus capsular polysaccharide types 5 and 8. J Infect Dis (1991) 1.05
Nontoxigenic vibrio Cholerae O1 bacteremia: case report and review. Eur J Clin Microbiol Infect Dis (2000) 1.04
Characterization and nucleotide sequence of CARB-6, a new carbenicillin-hydrolyzing beta-lactamase from Vibrio cholerae. Antimicrob Agents Chemother (1999) 1.03
Reactivity of coagulase-negative staphylococci isolated from cow and goat milk with monoclonal antibodies to Staphylococcus aureus capsular polysaccharide types 5 and 8. J Clin Microbiol (1990) 1.02
Murine immunoprotective activity of Klebsiella pneumoniae cell surface preparations: comparative study with ribosomal preparations. Infect Immun (1981) 1.01
Respiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus. Infect Immun (1996) 1.00
An algorithm based on one or two nasal samples is accurate to identify persistent nasal carriers of Staphylococcus aureus. Clin Microbiol Infect (2011) 1.00
Comparison of bacteriostatic and bactericidal activity of 13 essential oils against strains with varying sensitivity to antibiotics. Lett Appl Microbiol (2008) 0.99
[Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins]. Presse Med (1985) 0.98
Optimization of network robustness to waves of targeted and random attacks. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 0.97
Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid. Infect Immun (2001) 0.97
[Bacterial flora in gastric juice taken at endoscopy in 93 normal subjects]. Pathol Biol (Paris) (1986) 0.96
Efficiency of blood culture bottles for the fungal sterility testing of corneal organ culture media. Br J Ophthalmol (2005) 0.96
Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1. Microbiology (1999) 0.96
Characterization of a beta-lactamase from Pasteurella multocida. Ann Inst Pasteur Microbiol (1988) 0.94
Epidemiology of Staphylococcus aureus in patients with cystic fibrosis. Epidemiol Infect (1994) 0.94
A 5-year epidemiological study of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a medium- and long-stay neurological unit. J Appl Microbiol (2000) 0.94
Outbreak of postoperative shoulder arthritis due to Propionibacterium acnes infection in nondebilitated patients. Infect Control Hosp Epidemiol (2006) 0.93
Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations. Infect Immun (1979) 0.93
Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents. J Clin Microbiol (1991) 0.92
Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital. Clin Microbiol Infect (2004) 0.91
Dysphagia lusoria: a case report and review of diagnosis and treatment in adults. Am J Gastroenterol (1982) 0.91
Sensitivity and rapidity of blood culture bottles in the detection of cornea organ culture media contamination by bacteria and fungi. Br J Ophthalmol (2002) 0.91
Further delineation of the DOOR syndrome. Clin Dysmorphol (2000) 0.91
Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats. Neurosci Lett (2001) 0.91
Incidence and aetiology of fractures of the facio-maxillary skeleton in Trivandrum: a retrospective study. Br J Oral Maxillofac Surg (1986) 0.90
Comparison of various methods and reagents for species identification of Staphylococcus aureus positive or negative for the mecA gene. APMIS (1993) 0.90
Phenotypic study of resistance of beta-lactamase-inhibitor-resistant TEM enzymes which differ by naturally occurring variations and by site-directed substitution at Asp276. Antimicrob Agents Chemother (1998) 0.88
Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J Am Soc Nephrol (2000) 0.88
Sequence of the halobacterial glycosaminoglycan. J Biol Chem (1987) 0.88
Nonlinear identification of NMR spin systems by adaptive filtering. J Magn Reson (2000) 0.88
Nosocomial transmission of NDM-1-producing Escherichia coli within a non-endemic area in France. Clin Microbiol Infect (2012) 0.87
Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett (2003) 0.87
Bacterial vaginosis: prevalence and predictive value for premature delivery and neonatal infection in women with preterm labour and intact membranes. Eur J Obstet Gynecol Reprod Biol (2003) 0.87
[Unusual development of a human pasteurellosis after a cat bite]. Nouv Presse Med (1976) 0.86
[Distinction between beta-lactamases of immunotypes 1 or 2 using a new beta-lactam antbiotic (author's transl)]. Ann Microbiol (Paris) (1976) 0.86
Biochemical, immunological and physicochemical comparisons between OHIO-1 and four SHV-type beta-lactamases. FEMS Microbiol Lett (1989) 0.86
Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res (2004) 0.86
Pallidal and thalamic neurostimulation in severe tardive dystonia. J Neurol Neurosurg Psychiatry (2001) 0.85
Use of a pair of blood culture bottles for sterility testing of corneal organ culture media. Br J Ophthalmol (2001) 0.85